(Q35150278)

6 August 2017

title

Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis (English)

1 reference

6 August 2017

1 reference

K. C. Haltalin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4574641

6 February 2023

J. D. Nelson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4574641

6 February 2023

H. T. Kusmiesz

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4574641

6 February 2023

language of work or name

English

0 references

publication date

1 April 1973

1 reference

full work available at URL

6 August 2017

https://europepmc.org/articles/PMC1648332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4574641

https://europepmc.org/articles/PMC1648332?pdf=render

6 February 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:4574641

https://syndication.highwire.org/content/doi/10.1136/adc.48.4.305

6 February 2023

1 reference

https://api.crossref.org/works/10.1136/ADC.48.4.305

Archives of Disease in Childhood

6 February 2023

published in

1 reference

6 August 2017

volume

48

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

305-312

1 reference

In-vitro susceptibility of E. coli, Shigellae and Salmonellae to kanamycin and therapeutic implications

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648332

Antibiotic susceptibility testing by a standardized single disk method

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648332

Microbioassay of antimicrobial agents

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648332

Treatment of acute diarrhea in outpatients. Double-blind study comparing ampicillin and placebo

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648332

<i>In vitro</i> Effectiveness of Four Cephalosporins against Shigellae and Clinical Ineffectiveness of Cephaloglycin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648332

Antibiotic resistance in Shigella mediated by R factors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648332

NEGGRAM (NALIDIXIC ACID): A NEW ANTIMICROBIAL CHEMOTHERAPEUTIC AGENT.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648332

NALIDIXIC ACID IN INFECTIONS OF URINARY TRACT. LABORATORY AND CLINICAL INVESTIGATIONS.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648332

Resistance of shigellae to ampicillin and other antibiotics. Its clinical and epidemiological implications.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1648332

Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid

27 September 2018

1 reference

12 December 2020

Comparison of orally absorbable and nonabsorbable antibiotics in shigellosis. A double-blind study with ampicillin and neomycin

1 reference

12 December 2020

Comparison of intramuscular and oral ampicillin therapy for shigellosis

1 reference

12 December 2020

Antibiotic resistance of Shigella sonnei

1 reference

12 December 2020

Failure of Furazolidone Therapy in Shigellosis

1 reference

12 December 2020

A clinical study of wintomylon in the treatment of shigellosis

1 reference

12 December 2020

Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis

1 reference

12 December 2020

Assay of antibacterial activity in serum. A useful guide for complex antimicrobial therapy

1 reference

12 December 2020

NEGGRAM (NALIDIXIC ACID) IN THE TREATMENT OF URINARY INFECTIONS

1 reference

12 December 2020

NEGRAM (1-ETHYL-7-METHYL-1,8-NAPHTHYRIDINE-4-ONE-3-CARBOXYLIC ACID): A NEW ANTIBACTERIAL AGENT FOR THE TREATMENT OF URINARY INFECTION. REPORT OF A TRIAL IN GENERAL PRACTICE

1 reference

12 December 2020

IN VITRO SUSCEPTIBILITY OF SHIGELLAE TO SODIUM SULFADIAZINE AND TO EIGHT ANTIBIOTICS

1 reference

12 December 2020

Treatment of sonne dysentery

series ordinal

16

1 reference

https://api.crossref.org/works/10.1136/ADC.48.4.305

6 February 2023

Identifiers

DOI

10.1136/ADC.48.4.305

1 reference

6 August 2017

1 reference

6 August 2017

1 reference